Home > Balance Sheet > PIRAMAL PHARMA

PIRAMAL PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹3,393 Cr₹2,645 Cr₹3,812 Cr₹2,903 Cr₹2,560 Cr

What is the latest Total Non-Current Liabilities ratio of PIRAMAL PHARMA ?

The latest Total Non-Current Liabilities ratio of PIRAMAL PHARMA is ₹3,393 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹3,393 Cr
Mar2024₹2,645 Cr
Mar2023₹3,812 Cr
Mar2022₹2,903 Cr
Mar2021₹2,560 Cr

How is Total Non-Current Liabilities of PIRAMAL PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹3,393 Cr
28.29
Mar2024 ₹2,645 Cr
-30.62
Mar2023 ₹3,812 Cr
31.33
Mar2022 ₹2,903 Cr
13.37
Mar2021 ₹2,560 Cr -

Compare Total Non-Current Liabilities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹21,320.4 Cr -2.4% 2.4% -11.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-2.4%

2.4%

-11.9%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses